Axel Semjonow
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 98
- Prostate Cancer Diagnosis and Treatment 87
-
- Statistical Methods in Clinical Trials 13
- Co-authors
- L. HertleElke EltzeKlaus JungCarsten StephanBurkhard BrandtF. OberpenningMichael LeinStefan A. Loening
- Journals
- The Journal of Urology (13 papers)Clinical Chemistry (7 papers)The Prostate (7 papers)The International Journal of Biological Markers (7 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Axel Semjonow
164 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 746
- Urology 268
- Rheumatology 503
- Oncology 797
Countries citing papers authored by Axel Semjonow
This map shows the geographic impact of Axel Semjonow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Semjonow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Semjonow more than expected).
Fields of papers citing papers by Axel Semjonow
This network shows the impact of papers produced by Axel Semjonow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Semjonow. The network helps show where Axel Semjonow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Axel Semjonow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 4 | |
| 6 | 2019 | 8 | |
| 7 | 2019 | 3 | |
| 8 | 2018 | 11 | |
| 9 | 2016 | 18 | |
| 10 | 2015 | 4 | |
| 11 | 2014 | 51 | |
| 12 | 2013 | 4 | |
| 13 | 2011 | 15 | |
| 14 | 2010 | 53 | |
| 15 | 2009 | 12 | |
| 16 | 2008 | 3 | |
| 17 | 2002 | 14 | |
| 18 | Tumour markers in prostate cancer: EGTM recommendations | 1999 | 43 |
| 19 | 1999 | 6 | |
| 20 | 1995 | 3 |
About Axel Semjonow
Axel Semjonow is a scholar working on Pulmonary and Respiratory Medicine, Statistics and Probability, Rheumatology, Cancer Research and Obstetrics and Gynecology, having authored 170 papers that have together received 4.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (98 papers), Prostate Cancer Diagnosis and Treatment (87 papers), Bladder and Urothelial Cancer Treatments (23 papers), Urologic and reproductive health conditions (16 papers), Statistical Methods in Clinical Trials (13 papers), Molecular Biology Techniques and Applications (11 papers), Cancer, Lipids, and Metabolism (10 papers) and Ureteral procedures and complications (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Cancer Research (746 citations), Urology (268 citations), Rheumatology (503 citations) and Oncology (797 citations). Axel Semjonow has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include L. Hertle, Elke Eltze, Klaus Jung, Carsten Stephan, Burkhard Brandt, F. Oberpenning, Michael Lein, Stefan A. Loening, Henning Cammann and Kurt Miller. Their work appears in journals such as The Journal of Urology, Clinical Chemistry, The Prostate, The International Journal of Biological Markers and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.